| Associate Manager- RIM |
Hyderabad (Office) |
India |
Development |
Innovative Medicines |
Research & Development |
08 Oktober 2024 |
| Senior Clinical Research Associate |
Field Non-Sales (USA) |
USA |
Development |
Innovative Medicines |
Research & Development |
08 Oktober 2024 |
| Director, Development Unit Management |
Basel (City) |
Switzerland |
Development |
Innovative Medicines |
Research & Development |
16 Oktober 2024 |
| GCP Inspection Project Manager |
London (The Westworks) |
United Kingdom |
Development |
Innovative Medicines |
Quality |
16 Oktober 2024 |
| Senior Expert Science & Technology, Analytical Development |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
16 Oktober 2024 |
| RA Operational Excellence Junior Associate – MEA |
Dubai |
Utd.Arab Emir. |
Development |
Innovative Medicines |
Research & Development |
16 Oktober 2024 |
| Senior Principal Clinical Data Standards Specialist |
Mumbai (Office) |
India |
Development |
Innovative Medicines |
Research & Development |
18 Oktober 2024 |
| Medical Safety and Processes Manager |
Barcelona Gran Vía |
Spain |
Development |
Innovative Medicines |
Research & Development |
18 Oktober 2024 |
| Study Start Up Senior Lead |
Dublin (Novartis Corporate Center (NOCC)) |
Ireland |
Development |
Innovative Medicines |
Research & Development |
18 Oktober 2024 |
| RA Specialist |
Croatia |
Croatia |
Development |
Innovative Medicines |
Research & Development |
18 Oktober 2024 |
| Director of Patient-Centered Outcomes |
London (The Westworks) |
United Kingdom |
Development |
Innovative Medicines |
Research & Development |
18 Oktober 2024 |
| Gerente de Operações Estratégicas e Compliance Jr. |
Santo Amaro |
Brazil |
Development |
Innovative Medicines |
Research & Development |
18 Oktober 2024 |
| Country Patient Safety Head - France |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
Development |
Innovative Medicines |
Research & Development |
17 Oktober 2024 |
| Senior Expert Technical Development- Drug Product Project Lead |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
17 Oktober 2024 |
| Vendor Alliance Lead Associate Director |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
17 Oktober 2024 |
| Global Program Safety Lead - Immunology |
Basel (City) |
Switzerland |
Development |
Innovative Medicines |
Research & Development |
17 Oktober 2024 |
| Global Program Safety Lead - Immunology |
London (The Westworks) |
United Kingdom |
Development |
Sandoz |
Research & Development |
17 Oktober 2024 |
| Strategy Director, Clinical Development |
Basel (City) |
Switzerland |
Development |
Innovative Medicines |
Research & Development |
17 Oktober 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
09 Oktober 2024 |
| Feasibility Manager |
INSURGENTES |
Mexico |
Development |
Innovative Medicines |
Research & Development |
16 Oktober 2024 |
| Patient Safety Manager |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
Development |
Innovative Medicines |
Research & Development |
04 September 2024 |
| Director Science & Technology |
Basel (City) |
Switzerland |
Development |
Innovative Medicines |
Research & Development |
16 Oktober 2024 |
| SSO Study Start-Up Manager |
London (The Westworks) |
United Kingdom |
Development |
Innovative Medicines |
Research & Development |
16 Oktober 2024 |
| Senior Clinical Research Associate (Remote) |
Field Non-Sales (USA) |
USA |
Development |
Innovative Medicines |
Research & Development |
17 Oktober 2024 |
| Clinical Biospecimen Senior Scientist |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
03 September 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
09 Oktober 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
09 Oktober 2024 |
| Expert Science & Technology |
Changshu (Jiangsu Province) |
China |
Development |
Innovative Medicines |
Research & Development |
03 September 2024 |
| Regulatory Affairs Manager |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
01 September 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
09 Oktober 2024 |
| Ethics, Risk & Compliance Manager |
Selangor |
Malaysia |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
22 Augustus 2024 |
| Associate Director ERC Risk&Operations, Corporate Functions |
Selangor |
Malaysia |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
29 Augustus 2024 |
| Sr Manager/Manager-Monitoring |
Shanghai (Shanghai) |
China |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
18 Juli 2024 |
| Head DPDAI China |
Shanghai (Shanghai) |
China |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
14 Oktober 2024 |
| Manager- Data Privacy Review and Remediation |
Selangor |
Malaysia |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
14 Oktober 2024 |
| Risk & Assurance Manager |
Mumbai (Head Office) |
India |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
16 Oktober 2024 |
| Country ERC Head, India |
Mumbai (Office) |
India |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
16 Oktober 2024 |
| Manager- Data Privacy Review and Remediation |
Telangana |
India |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
10 Oktober 2024 |
| Associate Director - Risk & Assurance, EUROPE |
Prague |
Czech Republic |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
11 Oktober 2024 |
| Associate Director, Data Privacy, Digital & AI |
East Hanover |
USA |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
04 September 2024 |
| R2R Accountant |
Moscow (City) |
Russian Fed. |
Finance |
CTS |
Audit & Finance |
25 Juli 2024 |
| Associate, Record-to-Report |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Finance |
CTS |
Audit & Finance |
26 Juni 2024 |
| Treasury Manager |
Moscow (City) |
Russian Fed. |
Finance |
CTS |
Audit & Finance |
20 Juni 2024 |
| Manager, Financial Control & Compliance (FC&C) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Finance |
CTS |
Audit & Finance |
06 Oktober 2024 |
| Order to Cash Radioligand Therapy Sr. Specialist |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
06 Augustus 2024 |
| Record to Report Specialist |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
05 September 2024 |
| Order Management Specialist - Temporary |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
25 September 2024 |
| R2R Specialist - Inventory |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
28 Juli 2024 |
| BPA Planning Process, RLT |
Baarle Nassau |
Netherlands |
Finance |
Innovative Medicines |
Audit & Finance |
05 Augustus 2024 |
| RLT Sasayama_Associate_Finance Business Planning and Analysis |
Sasayama |
Japan |
Finance |
Innovative Medicines |
Audit & Finance |
17 September 2024 |